Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?

Journal of Business Ethics 94 (2):211-224 (2010)

Abstract
Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corporate social responsibility (CSR) perspective. In this article, we use several elements of CSR, emphasising consumer autonomy and safety, to analyse differences in DTCA practices within two different policy contexts, the United States of America and the European Union (EU). Doing so results in an alternative analysis of the struggle between proponents and opponents of DTCA from a CSR perspective, adding an alternative view on this debate.
Keywords corporate social responsibility (CSR)  pharmaceutical industry  direct-to-consumer-advertising (DTCA)  consumer safety
Categories (categorize this paper)
DOI 10.1007/s10551-009-0257-z
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

Our Archive


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 46,425
Through your library

References found in this work BETA

View all 15 references / Add more references

Citations of this work BETA

Add more citations

Similar books and articles

Analytics

Added to PP index
2009-11-23

Total views
69 ( #127,152 of 2,286,384 )

Recent downloads (6 months)
8 ( #128,097 of 2,286,384 )

How can I increase my downloads?

Downloads

My notes

Sign in to use this feature